Oneness Biotech Statistics

Total Valuation

Oneness Biotech has a market cap or net worth of EUR 1.46 billion. The enterprise value is 1.28 billion.

Market Cap	1.46B
Enterprise Value	1.28B

Important Dates

The last earnings date was Friday, November 8, 2024.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+1.24%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	307.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	4.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-36.04
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-109.20

Financial Position

The company has a current ratio of 39.99, with a Debt / Equity ratio of 0.03.

Current Ratio	39.99
Quick Ratio	39.02
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.99
Interest Coverage	-119.47

Financial Efficiency

Return on equity (ROE) is -9.08% and return on invested capital (ROIC) is -4.93%.

Return on Equity (ROE)	-9.08%
Return on Assets (ROA)	-4.80%
Return on Capital (ROIC)	-4.93%
Revenue Per Employee	73,656
Profits Per Employee	-826,298
Employee Count	43
Asset Turnover	0.01
Inventory Turnover	0.40

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -49.39% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-49.39%
50-Day Moving Average	19.81
200-Day Moving Average	23.67
Relative Strength Index (RSI)	35.68
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Oneness Biotech had revenue of EUR 3.17 million and -35.53 million in losses. Loss per share was -0.07.

Revenue	3.17M
Gross Profit	1.78M
Operating Income	-32.11M
Pretax Income	-36.05M
Net Income	-35.53M
EBITDA	-20.23M
EBIT	-32.11M
Loss Per Share	-0.07

Full Income Statement

Balance Sheet

The company has 202.33 million in cash and 11.63 million in debt, giving a net cash position of 190.70 million.

Cash & Cash Equivalents	202.33M
Total Debt	11.63M
Net Cash	190.70M
Net Cash Per Share	n/a
Equity (Book Value)	382.03M
Book Value Per Share	0.77
Working Capital	204.93M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.87 million and capital expenditures -1.86 million, giving a free cash flow of -11.73 million.

Operating Cash Flow	-9.87M
Capital Expenditures	-1.86M
Free Cash Flow	-11.73M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	56.22%
Operating Margin	-1,013.80%
Pretax Margin	-1,138.14%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-370.28%

Dividends & Yields

Oneness Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-1.24%
Shareholder Yield	-1.24%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Oneness Biotech has an Altman Z-Score of 58.15.

Altman Z-Score	58.15
Piotroski F-Score	n/a